Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
160,378,503
-
Share change
-
+4,797,227
-
Total reported value
-
$5,606,611,256
-
Put/Call ratio
-
124%
-
Price per share
-
$34.96
-
Number of holders
-
348
-
Value change
-
+$145,066,700
-
Number of buys
-
160
-
Number of sells
-
166
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q4 2024
As of 31 Dec 2024,
IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by
348 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
160,378,503 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BlackRock, Inc., Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, Bellevue Group AG, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and Tweedy, Browne Co LLC.
This page lists
348
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.